Skip to main content
SpringerLink
Log in

Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

Gallbladder cancers (GBC) are associated with high disease-specific mortality rates because of no means of early detection and effective therapies. In this study, we investigated CD146 expression, microvessel densities, and lymph vessel densities in 108 adenocarcinomas, 15 gallbladder polyps, 35 chronic cholecystitis tissues, and 46 peritumoral tissues using immunohistochemistry. We demonstrated that positive CD146 expression, and average microvessel and lymph vessel counts in gallbladder adenocarcinomas were significantly higher than those in peritumoral tissues, polyps, and chronic cholecystitis (ps < 0.01). Positive CD146 expression, and average microvessel and lymph vessel counts were also significantly lower in cases with well-differentiated adenocarcinoma, maximal tumor diameter <2 cm, no metastasis of lymph node, and no invasion of regional tissues than in cases with poorly differentiated adenocarcinoma, maximal tumor diameter ≥2 cm, metastasis in lymph nodes, and invasion of regional tissues (p < 0.05 or p < 0.01). Univariate Kaplan–Meier analysis showed that increased expression of CD146 (p = 0.056), higher average microvessel counts (p < 0.05), and lymph vessel counts (p < 0.05) were associated with decreased overall survival. Multivariate Cox regression analysis showed that average microvessel and lymph vessel counts (ps < 0.05) were independent prognostic predictors in gallbladder adenocarcinoma. Our study suggested that the elevated expression of CD146, angiogenesis, and lymphangiogenesis might be closely related to progression, invasion, metastasis, and prognosis of gallbladder adenocarcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jones RS. Carcinoma of the gallbladder. Surg Clin North Am. 1990;70:1419–28.

    PubMed  CAS  Google Scholar 

  2. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 1995;75:171–90.

    Article  PubMed  CAS  Google Scholar 

  3. Ootani T, Shirai Y, Tsukada K, Muto T. Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer. 1992;69:2647–52.

    Article  PubMed  CAS  Google Scholar 

  4. Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am. 2010;39:331–42.

    Article  PubMed  Google Scholar 

  5. Gatto M, Bragazzi MC, Semeraro R, et al. Cholangiocarcinoma: update and future perspectives. Dig Liver Dis. 2010;42:253–60.

    Article  PubMed  CAS  Google Scholar 

  6. Hawkins WG, DeMatteo RP, Jarnagin WR, Ben-Porat L, Blumgart LH, Fong Y. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11:310–5.

    Article  PubMed  Google Scholar 

  7. Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am. 2010;39:331–42.

    Article  PubMed  Google Scholar 

  8. Maurya SK, Tewari M, Mishra RR. Genetic aberrations in gallbladder cancer. Surg Oncol. 2010; Sep 28. [Epub ahead of print]

  9. Loges S, Clausen H, Reichelt U, Bubenheim M, Erbersdobler A, Schurr P, et al. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis. Clin Cancer Res. 2007;13:76–80.

    Article  PubMed  CAS  Google Scholar 

  10. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–4.

    Article  PubMed  CAS  Google Scholar 

  11. He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta. 2004;1654:3–12.

    PubMed  CAS  Google Scholar 

  12. Delatorre NG, Buley I, Wass JA, et al. Angiogenesis and lymphangiogenesis in thyroid proliferative lesions: relationship to type and tumor behaviors. Endocr Relat Cancer. 2006;13:934–44.

    Google Scholar 

  13. Aldovinni D, Demichelis F, Doglioni C, Di Vizio D, Galligioni E, Brugnara S, et al. MCAM expression as marker of prognosis in epithelial ovarian cancer. Int J Cancer. 2006;119:1920–6.

    Article  Google Scholar 

  14. Hasan J, Byers R, Jayson GC. Intra-tumoural microvessel density in human solid tumours. Br J Cancer. 2002;86:1566–77.

    Article  PubMed  CAS  Google Scholar 

  15. Beenken SW, Bland KI. Biomarkers for breast cancer. Minerva Chir. 2002;57:437–48.

    PubMed  CAS  Google Scholar 

  16. Legan M. New marker of angiogenesis CD105 (endoglin): diagnostic, prognostic and therapeutic role. Radiol Oncol. 2005;39:253–9.

    Google Scholar 

  17. Mineo TC, Ambrogi V, Baldi A, Rabitti C, Bollero P, Vincenzi B, et al. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB–IIA non-small cell lung cancer. J Clin Pathol. 2004;57:591–7.

    Article  PubMed  CAS  Google Scholar 

  18. Sundar SS, Ganesan TS. Role of lymphangiogenesis in cancer. J Clin Oncol. 2007;25:4298–07.

    Article  PubMed  CAS  Google Scholar 

  19. Mumprecht V, Detmar M. Lymphangiogenesis and cancer metastasis. J Cell Mol Med. 2009;13:1405–16.

    Article  PubMed  CAS  Google Scholar 

  20. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s and a subset of angiosarcomas. Mod Pathol. 2002;15:434–40.

    Article  PubMed  Google Scholar 

  21. Chu AY, Litzky LA, Pasha TL, Acs G, Zhang PJ. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Modern Pathol. 2005;18:105–10.

    Article  CAS  Google Scholar 

  22. Lehmann JM, Riethmuller G, Johnson JP. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA. 1989;86:9891–5.

    Article  PubMed  CAS  Google Scholar 

  23. Ouhtit A, Gaur RL, Abd Elmageed ZY, Fernando A, Thouta R, Trappey AK, et al. Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. Biochim Biophys Acta. 2009;1795:130–6.

    PubMed  CAS  Google Scholar 

  24. Garcia S, Dales JP, Charafe-Jauffret E, Carpentier-Meunier S, Andrac-Meyer L, Jacquemier J, et al. Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and C-Met and with proteomic basal-like phenotype. Hum Pathol. 2007;38:830–41.

    Article  PubMed  CAS  Google Scholar 

  25. Watson-Hurst K, Becker D. The role of N-cadherin, MCAM and beta3 integrin in melanoma progression, proliferation, migration and invasion. Cancer Biol Ther. 2006;5:1375–82.

    Article  PubMed  CAS  Google Scholar 

  26. Yang H, Wang S, Liu Z, Wu MH, McAlpine B, Ansel J, et al. Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability. Gene. 2001;265:133–45.

    Article  PubMed  CAS  Google Scholar 

  27. Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am. 2010;39:331–42.

    Article  PubMed  Google Scholar 

  28. Yamagiwa H, Tomiyama H, Yoshimura H. Histogenesis of carcinoma of gallbladder. Histological study of serial sections of 1000 cases of resected gallbladder. Rinsho Byori. 1986;34:475–80.

    PubMed  CAS  Google Scholar 

  29. Dowling GP, Kelly JK. The histogenesis of adenocarcinoma of the gallbladder. Cancer. 1986;58:1702–8.

    Article  PubMed  CAS  Google Scholar 

  30. Sanada Y, Yoshida K, Ohara M, Tsutani Y. Expression of orotate phosphoribosyltransferase (OPRT) in hepatobiliary and pancreatic carcinoma. Pathol Oncol Res. 2007;13:105–13.

    Article  PubMed  Google Scholar 

  31. Chang HJ, Yoo BC, Kim SW, Lee BL, Kim WH. Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas. Pathol Oncol Res. 2007;13:326–35.

    Article  PubMed  CAS  Google Scholar 

  32. Tucek S, Tomasek J, Halámkova J. Bile duct malignancies. Klin Onkol. 2010;23:231–41.

    PubMed  CAS  Google Scholar 

  33. Malik IA. Gallbladder cancer: current status. Expert Opin Pharmacother. 2004;5:1271–7.

    Article  PubMed  CAS  Google Scholar 

  34. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3:401–10.

    Article  PubMed  CAS  Google Scholar 

  35. Sugawara Y, Makuuchi M, Harihara Y, Noie T, Inoue K, Kubota K, et al. Tumor angiogenesis in gallbladder carcinoma. Hepatogastroenterology. 1999;46:1682–6.

    PubMed  CAS  Google Scholar 

  36. Giatromanolaki A, Sivridis E, Koukourakis MI, Polychronidis A, Simopoulos C. Prognostic role of angiogenesis in operable carcinoma of the gallbladder. Am J Clin Oncol. 2002;25:38–41.

    Article  PubMed  CAS  Google Scholar 

  37. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1–8.

    Article  PubMed  CAS  Google Scholar 

  38. Iiizumi M, Liu W, Pai SK, Furuta E, Watabe K. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta. 2008;1786:87–104.

    PubMed  CAS  Google Scholar 

  39. Dumoff KL, Chu C, Xu X, Pasha T, Zhang PJ, Acs G. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix. Mod Pathol. 2005;18:97–104.

    Article  PubMed  CAS  Google Scholar 

  40. Kadota K, Huang CL, Liu D, Ueno M, Kushida Y, Haba R, et al. The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Eur J Cancer. 2008;44:1057–67.

    Article  PubMed  CAS  Google Scholar 

  41. Hardavella G, Arkoumani E, Dalavanga Y, Galanis P, Agnantis NJ, Constantopoulos S, et al. Prognostic impact of lymphangiogenesis and lymphatic invasion (CD105 expression) in small cell lung carcinoma. Anticancer Res. 2008;28:343–7.

    PubMed  Google Scholar 

  42. Thelen A, Scholz A, Benckert C, Weichert W, Dietz E, Wiedenmann B, et al. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Ann Surg Oncol. 2008;15:791–9.

    Article  PubMed  Google Scholar 

  43. Kristiansen G, Yu Y, Schlüns K, Sers C, Dietel M, Petersen I. Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer. Anal Cell Pathol. 2003;25:77–81.

    PubMed  CAS  Google Scholar 

  44. Walgenbach-Bruenagel G, Tolba RH, Varnai AD, Bollmann M, Hirner A, Walgenbach KJ. Detection of lymphatic invasion in early stage primary colorectal cancer with the monoclonal antibody D2-40. Eur Surg Res. 2006;38:438–44.

    Article  PubMed  CAS  Google Scholar 

  45. Jackson DG. Lymphatic markers, tumour lymphangiogenesis and lymph node metastasis. Cancer Treat Res. 2007;135:39–53.

    Article  PubMed  CAS  Google Scholar 

  46. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563–72.

    Article  PubMed  CAS  Google Scholar 

  47. Shih IM. The role of CD146 (Mel-CAM) in biology and pathology. J Pathol. 1999;189:4–11.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of General Surgery, Third Affiliated Hospital of Nanchang University, Nanchang, 300008, China

    Wenjun Wang

  2. Research Laboratory of Hepatobiliary Diseases, Second Xiangya Hospital, Central South University, Changsha, 410011, China

    Zhu-lin Yang, Jie-qiong Liu, Song Jiang & Xiong-ying Miao

Authors
  1. Wenjun Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhu-lin Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jie-qiong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Song Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiong-ying Miao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhu-lin Yang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, W., Yang, Zl., Liu, Jq. et al. Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma. Tumor Biol. 33, 173–182 (2012). https://doi.org/10.1007/s13277-011-0260-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-011-0260-8

Keywords

Search

Navigation